Effects of raloxifene on development of the methotrexate-induced changes in bone mechanical properties of male rats.

Journal Title: Pharmacological Reports - Year 2007, Vol 59, Issue 3

Abstract

Methotrexate, a cytostatic and immunosuppressive drug, has been reported to deteriorate the osseous system. Raloxifene, a selective estrogen receptor modulator, is used in the prevention and treatment of postmenopausal osteoporosis. There is a lack of data on possible ways of preventing the unwanted skeletal effects of prolonged immunosuppressive therapy. The aim of the present study was to investigate the effects of raloxifene on mechanical properties of the femur in male rats administered methotrexate. The experiments were carried out on mature male Wistar rats, which were divided into 6 groups: controls, rats administered raloxifene hydrochloride (5 mg/kg po), rats administered methotrexate (0.5 mg/kg po or im), and rats administered raloxifene hydrochloride (5 mg/kg po) plus methotrexate (0.5 mg/kg po or im). Raloxifene was administered for 28 days and methothrexate was administered for the first 10 days of the experiment. After 28 days of drug administration, mechanical parameters of the whole femur were determined: the extrinsic stiffness, the ultimate load and the breaking load, deformation caused by the ultimate and breaking loads, and the load causing fracture of the femoral neck. Additionally, the mass of isolated femurs and their mineral and calcium content were determined. Intragastrically or intramuscularly administered methotrexate impaired the endurance of the tested bones. Administration of raloxifene alone had no significant effects on the mechanical parameters of the femur. Administration of raloxifene resulted in a reduction of the adverse changes in the osseous system induced by methotrexate. Concluding, the experiments demonstrated a protective action of raloxifene against the effects of methotrexate on the osseous system in male rats.

Authors and Affiliations

Barbara Nowińska, Urszula Cegieła, Joanna Folwarczna, Leszek Śliwiński, Ilona Kaczmarczyk-Sedlak, Maria Pytlik, Waldemar Janiec

Keywords

Related Articles

Clinical aspects of assessment of endothelial function.

Prevention and treatment of atherosclerosis is an important priority. Measurement of endothelial function has been reported as a useful tool for atherosclerosis research. Endothelium appear to integrate the injury of com...

Lack of effect of naltrexone on the spinal synergism between morphine and non steroidal anti-inflammatory drugs.

To enhance analgesia, the combinatorial use of analgesic drugs with proven efficacies is a widely-used strategy to reduce adverse side effects. The present study characterizes the antinociceptive interaction of intrathec...

Effect of 4-hydroxyandrost-4-ene-3,17-dione (formestane) on the bile secretion and metabolism of 4-(14)C-cholesterol to bile acids.

4-Hydroxyandrost-4-ene-3,17-dione (formestane) is a selective aromatase inhibitor. It is indicated for postmenopausal patients with advanced breast cancer. The aim of the present study was to investigate the effect of 4-...

Effects of baclofen and L-AP4 in passive avoidance test in rats after hypoxia-induced amnesia.

Hypoxia-induced cognitive deficits are mainly due to disturbances of the balance between the GABAergic and glutamatergic systems. Acquisition, consolidation and retention impairment in passive avoidance test, hypolocomot...

Antigenotoxic effect of genistein against 7,12-dimethylbenz[a]anthracene induced genotoxicity in bone marrow cells of female Wistar rats.

Carcinogen induced mutation in somatic cells leads to genetic instability, which is considered as an important facet of carcinogenesis. Agents that inhibit DNA adduct formation, stimulate DNA repair mechanisms, and posse...

Download PDF file
  • EP ID EP83930
  • DOI -
  • Views 102
  • Downloads 0

How To Cite

Barbara Nowińska, Urszula Cegieła, Joanna Folwarczna, Leszek Śliwiński, Ilona Kaczmarczyk-Sedlak, Maria Pytlik, Waldemar Janiec (2007). Effects of raloxifene on development of the methotrexate-induced changes in bone mechanical properties of male rats.. Pharmacological Reports, 59(3), 359-364. https://europub.co.uk/articles/-A-83930